ヒト血液凝固第XIII因子の安定化された水性液製剤
- 专利权人:
- ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー
- 发明人:
- 加藤 直子,近藤 修二
- 申请号：
- JP2008271636
- 公开号：
- JP5069661B2
- 申请日:
- 2008.10.22
- 申请国别(地区):
- JP
- 年份:
- 2012
- 代理人:
- 摘要：
PROBLEM TO BE SOLVED: To provide a stabilized water-based liquid formulation of human blood coagulation XIII factor containing at least one of galactose, sucrose, sorbitol, a glutamate and an aspartate as a stabilizer and produced by gene recombination technology.
SOLUTION: The stable water-based liquid formulation of human blood coagulation XIII factor, hardly decreased in biological activity even when kept for a long term and produced by gene recombination technology, is provided.
COPYRIGHT: (C)2009,JPO&INPIT
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII
- Pharmaceutical composition used for the prevention and / or treatment of diseases that develop and / or develop due to decreased or deficient activity of blood coagulation factor VIII and / or activated blood coagulation VIII
- PHARMACEUTICAL COMPOSITION USED FOR PREVENTION AND/OR TREATMENT OF DISEASE DEVELOPED AND/OR ADVANCED BY DECREASE OR DEFICIENCY IN ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII
- 血液凝固第VIII因子の機能代替抗体
- MULTISPECIFIC ANTIGEN-BINDING MOLECULES HAVING BLOOD COAGULATION FACTOR VIII (FVIII) COFACTOR FUNCTION-SUBSTITUTING ACTIVITY AND PHARMACEUTICAL FORMULATIONS CONTAINING SUCH MOLECULE AS ACTIVE INGREDIENT
